ADVFN US – Market Content Editor
-
InMode shares edge higher as company explores strategic options
Shares of InMode Ltd. (NASDAQ:INMD) gained about 2.5% in premarket trading on Monday after the company confirmed it is reviewing potential strategic alternatives. The medical technology firm said it has formed a special committee made up of independent directors to manage and oversee the evaluation process. The committee has engaged external legal and financial advisers…
-
Northfield Bancorp shares surge on Columbia Financial takeover agreement
Shares of Northfield Bancorp Inc (NASDAQ:NFBK) jumped nearly 12% in premarket trading on Monday after the bank agreed to be acquired by Columbia Financial Inc (NASDAQ:CLBK) in a transaction valued at about $597 million. The all-cash-and-stock deal, which has been unanimously approved by both boards, will create the third-largest regional bank headquartered in New Jersey,…
-
Devon Energy, Coterra shares dip after companies unveil all-stock merger
Shares of Devon Energy (NYSE:DVN) slid about 3% and Coterra Energy (NYSE:CTRA) fell roughly 4.2% in premarket trading on Monday after the two companies announced a stock-for-stock merger that will form one of the largest shale operators in the United States. Under the agreement, Coterra investors will receive 0.70 shares of Devon common stock for…
-
Pharming Group shares slide after FDA issues Complete Response Letter for Joenja
Shares of Pharming Group NV (NASDAQ:PHAR) dropped around 16.8% in premarket trading on Monday after the company disclosed that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration for its supplemental New Drug Application covering Joenja. The FDA said it has concerns about possible underdosing in lower-weight pediatric patients for…
-
Yext shares slide as CEO pulls takeover bid
Shares of Yext (NYSE:YEXT) sank about 13% on Monday after Chief Executive Officer Michael Walrath withdrew his earlier, non-binding proposal to buy the remaining shares of the company he does not already own for $9.00 per share in cash. Walrath told Yext’s board that he was unable to line up financing at the proposed valuation.…
-
Avalo Therapeutics shares jump as Guggenheim starts coverage with Buy
Shares of Avalo Therapeutics Inc (NASDAQ:AVTX) climbed about 5.8% in premarket trading on Monday after Guggenheim launched coverage on the stock with a Buy recommendation and a $50 price target. Guggenheim analyst Yatin Suneja said he is encouraged by Avalo’s IL-1β inhibitor, AVTX-009, which is being developed to treat hidradenitis suppurativa (HS), a chronic inflammatory…
-
VerifyMe shares climb after company restores Nasdaq listing compliance
Shares of VerifyMe Inc (NASDAQ:VRME) advanced about 3.5% in premarket trading on Monday after the company said it has returned to compliance with Nasdaq’s minimum bid price rule. The provider of brand protection and specialized logistics services confirmed it received official notification from Nasdaq stating that it now meets the requirement to maintain a share…
-
Five market themes to track in the coming week
A packed calendar of U.S. economic data and high-profile corporate earnings could shape market direction in the days ahead. Investors will be watching the U.S. labour market closely, while results from major technology names such as Alphabet (NASDAQ:GOOG) and Amazon (NASDAQ:AMZN) are set to dominate headlines. Outside tech, Eli Lilly (NYSE:LLY) may offer fresh signals…
-
Coty teams up with OpenAI to roll out ChatGPT Enterprise companywide
Coty Inc. (NYSE:COTY) said it has entered into a strategic partnership with OpenAI to introduce ChatGPT Enterprise across selected parts of its global organization, marking a key step in the beauty group’s broader artificial intelligence strategy. Under the collaboration, Coty employees in targeted functions will gain access to OpenAI’s AI models through the ChatGPT Enterprise…
-
Twist Bioscience shares jump 5% after revenue tops forecasts and outlook is lifted
Twist Bioscience Corporation (NASDAQ:TWST) reported fiscal first-quarter 2026 revenue that came in ahead of market expectations on Monday, prompting a rally in the stock, even though earnings fell short of forecasts. Shares of the biotech group were up about 5.16% in premarket trading following the announcement. Twist posted quarterly revenue of $103.7 million for the…